{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:38:47Z","timestamp":1791571127703,"version":"4.3.4"},"reference-count":75,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The thyroid gland is often involved in the development of neoplastic diseases, including lymphoproliferative disorders. The aim of this paper is to provide a comprehensive overview of the multiple interactions between lymphoma and thyroid. Through an extensive research among the literature, the relationship between lymphomas and thyroid can be established at various levels, and the possible interconnections are here summarized in 5 points: (1) the greater risk of lymphoma development in some thyroid diseases; (2) the primary thyroid lymphoma, with focus on issues related to the diagnosis, differential diagnosis, and treatment; (3) the incidence of thyroid involvement in primitive nodal lymphomas or in extranodal lymphomas of the other sites; (4) thyroid changes after treatment of lymphoma, in relation to the effects of radiation therapy and immuno\u2010chemotherapy; (5) the incidental findings of thyroid changes, on imaging, in patients with lymphoma, without a direct involvement of the gland in malignant disease.<\/jats:p><jats:p>In conclusion, issues that until now have been dealt with separately will therefore be analyzed in a unique paper, allowing a global view of the topic and emphasizing the need of a multidisciplinary approach. Future learning areas in this topic mainly relate to rapidly increasing the knowledge of imaging studies together with expanding the armamentarium of novel biological and targeting agents in lymphoma patients.<\/jats:p>","DOI":"10.1002\/hon.2504","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T07:06:35Z","timestamp":1519715195000},"page":"519-524","source":"Crossref","is-referenced-by-count":14,"title":["Lymphomas and thyroid: Bridging the gap"],"prefix":"10.1002","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7926-090X","authenticated-orcid":false,"given":"Salvatrice","family":"Mancuso","sequence":"first","affiliation":[{"name":"Department of Oncology, Haematology Unit University of Palermo School of Medicine  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Carlisi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology Unit University of Palermo School of Medicine  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariasanta","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology Unit University of Palermo School of Medicine  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Siragusa","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology Unit University of Palermo School of Medicine  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2016.07.006"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1428"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0036"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.955"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9653-8"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196205\/06)15:3<557::AID-CNCR2820150315>3.0.CO;2-H"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810601)47:11<2704::AID-CNCR2820471129>3.0.CO;2-G"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000044"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-36"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904083401404"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030465"},{"issue":"2","key":"e_1_2_9_13_1","first-page":"1421","article-title":"Prevalence and risk of cancer of focal thyroid Incidentaloma identified by 18F\u2010fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects","volume":"25","author":"Chen YK","year":"2005","journal-title":"Anticancer Res"},{"issue":"3","key":"e_1_2_9_14_1","first-page":"342","article-title":"Non\u2010Hodgkin's thyroid lymphoma associated with Hashimoto's thyroiditis","volume":"64","author":"Ahmed T","year":"2014","journal-title":"J Pak Med Assoc"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000150"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021194"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20022"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.018416"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm094"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2010.06.002"},{"key":"e_1_2_9_21_1","volume-title":"Thyroid nodules and cancer in the elderly","author":"Sajid\u2010Crokett S","year":"2015"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195707\/08)10:4<663::AID-CNCR2820100404>3.0.CO;2-V"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9371.151139"},{"issue":"6","key":"e_1_2_9_24_1","first-page":"2075","article-title":"Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre","volume":"40","author":"Alzouebi M","year":"2012","journal-title":"Int J Oncol"},{"issue":"5","key":"e_1_2_9_25_1","first-page":"5944","article-title":"Primary mediastinal large B\u2010cell lymphoma arising from thyroid in a renal recipient with Hashimoto's thyroiditis","volume":"8","author":"Wu F","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31817d7470"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-8-116"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.1941"},{"issue":"1","key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jcem.87.1.8156","article-title":"Primary thyroid lymphoma is a heterogeneous disease","volume":"87","author":"Thieblemont C","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-355"},{"issue":"1","key":"e_1_2_9_31_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12288-013-0312-x","article-title":"A case of advanced primary thyroid double\u2010hit B cell lymphoma in which complete remission has been maintained after high\u2010dose chemotherapy and autologous peripheral blood stem cell transplantation performed during the second remission, with a review of the literature","volume":"30","author":"Sekiguchi Y","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"e_1_2_9_32_1","first-page":"740241","article-title":"Maltoma of thyroid: a rare thyroid tumour","volume":"2013","author":"Latheef N","year":"2013","journal-title":"Case Rep Otolaryngol"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200005000-00001"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-004-0021-7"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2012.04.024"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.7863\/jum.2012.31.4.589"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(02)00134-1"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.3.1135"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2542"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq310"},{"issue":"4","key":"e_1_2_9_41_1","first-page":"609","article-title":"Focal thyroid lesions incidentally identified by integrated 18F\u2010FDG PET\/CT: clinical significance and improved characterization","volume":"47","author":"Choi JY","year":"2006","journal-title":"J Nucl Med"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-13-S2-S49"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1015-9584(10)60004-8"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1993.3.93"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6413-3-23"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.5603\/EP.2015.0001"},{"issue":"12","key":"e_1_2_9_47_1","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.5858\/2006-130-1850-FCAOLC","article-title":"Flow cytometric analysis of lymphomas: current status and usefulness","volume":"130","author":"Kaleem Z","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.2.6390"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0768-z"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2009.09.020"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO;2-1"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199407143310202"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.085"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/31803121"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2010.500301"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0523"},{"key":"e_1_2_9_61_1","first-page":"289","article-title":"Improving survival and preventing recurrence of diffuse large B\u2010cell lymphoma in younger patients: current strategies and future directions","volume":"6","author":"Karlin L","year":"2013","journal-title":"Onco Targets Ther Mar"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390104"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08606.x"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00941.x"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.73"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-423079"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-7071(00)00195-9"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108293250902"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr373"},{"key":"e_1_2_9_70_1","unstructured":"Campath Product Label.2007.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/103948s5070lbl.pdfAccessed September 13 2011."},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22008"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.0379"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2388"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1238"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-166"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.116"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2504","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:44:27Z","timestamp":1695012267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1002\/hon.2504"],"URL":"https:\/\/doi.org\/10.1002\/hon.2504","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]}}}